FDA.reportPublic FDA data

Cantharis

Manufacturer
SEVENE USA
Effective date
2025-05-22
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-06-01 02:33:39

Label at a glance#

ProductCantharis 200ck
Active ingredientLYTTA VESICATORIA
Label structure12 sections

Dosage and administration

(adults/children) Dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a physician.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT:

OTC - ACTIVE INGREDIENT SECTION

HOMEOPATHIC DILUTION OF HPUS Cantharis 200ck **C, K, CK, AND X ARE HOMEOPATHIC DILUTIONS

TRADITIONALLY USED FOR:

OTC - PURPOSE SECTION

Burns & blisters* - Bladder irritation / inflamation*

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

(adults/children) Dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a physician.

USE:

INDICATIONS & USAGE SECTION

Condition listed above or as directed by a physician.

WARNINGS:

WARNINGS SECTION

Stop use and ask a physician if symptoms persist for more than 3 days or worsen.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OTHER INFORMATION:

OTHER SAFETY INFORMATION

Store at room temperature.

OTC - DO NOT USE SECTION

Do not use if pellet-dispenser seal is broken.

INACTIVE INGREDIENT:

INACTIVE INGREDIENT SECTION

SUCROSE.

QUESTIONS?

OTC - QUESTIONS SECTION

INFO@OLLOIS.COM * www.ollois.com * MADE IN FRANCE. THIS HOMEOPATHIC DILUTION MAY NOT BE SUSEPTIBLE TO SCIENTIFIC MEASUREMENT.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

cantharis p1 200kcantharis p1 200k

label_ollois_CANTHARIS_200ck_PAGE2label_ollois_CANTHARIS_200ck_PAGE2

PAGE3_label_ollois_COMMONPAGE3_label_ollois_COMMON

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
76472-3010-12025-02-11C16284748780-12cef2736-8c0f-d83d-e063-dadaa90ab31fSevene USA (as PLD) - CANTHARIS 200ck (76472-3010)
76472-3010-12025-01-30C16284748780-12cef2736-8c0f-d83d-e063-dadaa90ab31fSevene USA (as PLD) - CANTHARIS 200ck (76472-3010)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76472-3010-1Cantharis200ck80 in 1 CYLINDERPELLET806

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76472-3010CANTHARIS 200CK (LYTTA VESICATORIA) PELLET [SEVENE USA]6Current NDC, Legacy NDC, 1 package rows20250523_c8d55407-73f9-9c5e-e053-2a95a90a3095.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76472-301076472-3010-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
LYTTA VESICATORIA3Q034RO3BTACTIB
SUCROSEC151H8M554IACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cantharis 200ckLYTTA VESICATORIASEVENE USAc8d55407-73f9-9c5e-e053-2a95a90a30952025-05-22WarningsExact identifier
ndc (package): 76472-3010-1
ndc (product): 76472-3010
ndc11 (package): 76472301001
spl id: 35b722d4-ce27-088e-e063-6394a90a9b8d
spl set id: c8d55407-73f9-9c5e-e053-2a95a90a3095

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.